Provention Bio

Company Drug

Q1 2023 financial report: AstraZeneca leads innovation in China, Sanofi’s sales in China decline

Fineline Cube Apr 28, 2023

Several multinational companies (MNCs) have released their Q1 2023 financials, showing a varied performance over...

Company Drug

InnoCare’s Zurletrectinib Wins NMPA Nod as China’s First Next-Gen TRK Inhibitor

Company Deals

Brii Biosciences Taps OpenBench AI Platform to Accelerate Drug Discovery

Company Deals

GSK Terminates Ideaya Synthetic Lethality Partnership, Returns Two Clinical Programs

Company Deals

B&K Corporation Debuts on HKEX in $900M IPO Backed by Burn Drug Pipeline